Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol.

Nadeeka N W DissanayakaDana PourzinalGerard J ByrneJihyun YangKatie L McMahonGregory M PontoneJohn D O'SullivanRobert AdamRoberta LittlefordMark ChatfieldAlexander LehnZoltan MariArnold Bakker

Published in: Pilot and feasibility studies (2023)

ClinicalTrials.gov, NCT04643327 . Registered on 25 November 2020.

Keyphrases

mild cognitive impairment
cognitive decline
randomized controlled trial
study protocol
clinical trial
phase iii
phase ii
open label
combination therapy